.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Deloitte
Chubb
Healthtrust
Merck
Citi
Dow
McKinsey
US Army
Moodys

Generated: November 20, 2017

DrugPatentWatch Database Preview

Iopromide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iopromide and what is the scope of iopromide patent protection?

Iopromide
is the generic ingredient in six branded drugs marketed by Bayer Hlthcare and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for iopromide. One supplier is listed for this compound.

Pharmacology for iopromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare
ULTRAVIST 370
iopromide
INJECTABLE;INJECTION020220-001May 10, 1995RXYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST 300
iopromide
INJECTABLE;INJECTION020220-002May 10, 1995RXYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST (PHARMACY BULK)
iopromide
INJECTABLE;INJECTION021425-002Sep 20, 2002RXYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST (PHARMACY BULK)
iopromide
INJECTABLE;INJECTION021425-003Mar 12, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST 240
iopromide
INJECTABLE;INJECTION020220-003May 10, 1995RXYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST (PHARMACY BULK)
iopromide
INJECTABLE;INJECTION021425-001Sep 20, 2002RXYesYes► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST 300 IN PLASTIC CONTAINER
iopromide
INJECTABLE;INJECTION020220-005Nov 18, 2008DISCNYesNo► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST 150
iopromide
INJECTABLE;INJECTION020220-004May 10, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: iopromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare
ULTRAVIST 150
iopromide
INJECTABLE;INJECTION020220-004May 10, 1995► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST 370
iopromide
INJECTABLE;INJECTION020220-001May 10, 1995► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST (PHARMACY BULK)
iopromide
INJECTABLE;INJECTION021425-003Mar 12, 2004► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST (PHARMACY BULK)
iopromide
INJECTABLE;INJECTION021425-002Sep 20, 2002► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST (PHARMACY BULK)
iopromide
INJECTABLE;INJECTION021425-001Sep 20, 2002► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST 300
iopromide
INJECTABLE;INJECTION020220-002May 10, 1995► Subscribe► Subscribe
Bayer Hlthcare
ULTRAVIST 240
iopromide
INJECTABLE;INJECTION020220-003May 10, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Queensland Health
Farmers Insurance
Cerilliant
Healthtrust
Mallinckrodt
Cipla
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot